UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 5

of 'Immunotherapy of non-small cell lung cancer with immune checkpoint inhibition'

5
TI
Phase 3, Randomized Trial (CheckMate 057) of Nivolumab vs Docetaxel in Advanced Non-Squamous (Non-SQ) Non-Small Cell Lung Cancer (NSCLC): Subgroup Analyses and Patient-Reported Outcomes (PROs)
AU
Horn L, Brahmer J, Reck M, Borghaei H, Spigel DR
SO
European Cancer Conference. 2015;European Society of Medical Oncology(2015)
 
AD